Hai-Lin Lu
Overview
Explore the profile of Hai-Lin Lu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lu H, Li L, Miao Y, Liang H, Zou J, You J, et al.
Gene
. 2023 Jun;
878:147581.
PMID: 37336270
Proopiomelanocortin (POMC) is a hormone precursor, and has been reported to participate in domestication. However, its effects on feeding habit domestication in fish are poorly understood. Mandarin fish (Siniperca chuatsi)...
2.
Zou J, Zhu Q, Liang H, Lu H, Liang X, He S
Int J Mol Sci
. 2022 Jun;
23(12).
PMID: 35743178
Regulation of food intake is associated with nutrient-sensing systems and the expression of appetite neuropeptides. Nutrient-sensing systems generate the capacity to sense nutrient availability to maintain energy and metabolism homeostasis....
3.
Chen C, Wu Y, Lu H, Liu K, Qin X
PeerJ
. 2022 Mar;
10:e13138.
PMID: 35313524
Background: Vascular calcification (VC) is the most widespread pathological change in diseases of the vascular system. However, we know poorly about the molecular mechanisms and effective therapeutic approaches of VC....
4.
Liang X, Feng Z, Liu F, Yan R, Yin L, Shen H, et al.
Exp Ther Med
. 2021 Dec;
23(1):51.
PMID: 34917180
Hepatocellular carcinoma (HCC) has a high mortality rate owing to its complexity. Identification of abnormally expressed genes in HCC tissues compared to those in normal liver tissues is a viable...
5.
Lu H, Xuan F, Luo Y, Qin X
Abdom Radiol (NY)
. 2021 Jul;
46(11):5417-5427.
PMID: 34302511
Objectives: This study seeks to assess the efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPS) combined with transarterial embolization/transarterial chemoembolization (TAE/TACE) in hepatocellular carcinoma (HCC) with portal hypertension and...
6.
Luo Y, Lu H, Song W, Xuan F
J Int Med Res
. 2021 Jul;
49(7):3000605211024840.
PMID: 34250825
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer mortality globally. In addition, most patients present in advanced stages with limited curative treatment options. Therefore, multidisciplinary treatment is often...
7.
Hsu K, Lu H, Kuan C, Wu J, Huang C, Lin P, et al.
Int J Environ Res Public Health
. 2021 Jan;
18(3).
PMID: 33499419
Aging is accompanied by changes in organ degeneration, and susceptibility to multiple diseases, leading to the frequent occurrence of adverse drug reactions resulting from polypharmacy (PP) and potentially inappropriate medications...
8.
Liang X, Feng Z, Liu F, Yan R, Yin L, Shen H, et al.
Cell Biol Int
. 2020 Aug;
44(11):2326-2333.
PMID: 32770827
Targeting cyclin-dependent kinases (CDKs) is a promising method of therapy for cancer. Unfortunately, the efficacy of CDK inhibitors in hepatocellular carcinoma (HCC) is limited, due in part to incomplete understanding...
9.
Liu R, Huang F, Guo M, Lu H, Zhu K, Qin W, et al.
Zhongguo Zhong Yao Za Zhi
. 2019 Jul;
44(11):2283-2291.
PMID: 31359655
To build up an identification method on cardiac glycosides in Taxillus chinensis and its Nerium indicum host, and evaluate the influence on medicine quality from host to T. chinensis, ultra-performance...
10.
Wang T, Trezise D, Ku P, Lu H, Hsu K, Hsu P
Int J Environ Res Public Health
. 2019 Jun;
16(12).
PMID: 31234455
Patients with high healthcare utilization are at increased risk of polypharmacy and drug interactions. This study investigated the changes in the number of medications, drug interactions and interaction severity in...